Hints and tips:
Related Special Reports
...However, a report authored by Timothy Doyle at the ACCF, a pro-business think-tank, argues that these ESG rating agencies are inconsistent and suffer from a series of biases, such as a tendency to award...
...Merck’s decision to test its drug in combination with chemotherapy will help it open a lead over Bristol-Myers Squibb, its closest rival in the field of immunotherapy....
...(CNBC) From Washington to Wall Street A decade after the financial crisis, former Treasury Secretary Timothy Geithner is at work at private equity group Warburg Pincus....
...“Why doesn’t Pfizer just buy Bristol-Myers today, given its floundering share price,” asked Timothy Anderson, an analyst at Bernstein, in a recent note to investors, adding that he expected the drugmaker...
...A nine-person instrumental ensemble is smoothly conducted by Timothy Myers....
...For example, a recent study by Johns Hopkins University suggests an important component of HAART – efavirenz (sold by Bristol-Myers Squibb, the pharmaceutical company, as Sustiva) – may contribute to cognitive...
...The US Food and Drug Administration has approved a breakthrough skin cancer drug created by Bristol-Myers Squibb....
...“I would think the pendulum has swung pretty far toward being risk-averse,” Ms Myers says....
...“The European Union is going to come together with an appropriate deal for Greece,” said Timothy Speiss, partner at Eisner LLP and practice leader of its personal wealth advisory group....
...Bristol Myers Squibb was a rare gainer, its shares lifting 1.7 per cent to $21.02 after the US Food and Drug Administration said analyses of its experimental diabetes drug showed it met the agency’s guidelines...
...In a break from the partisan divisions of recent days, Mr Obama will be joined in Fort Myers by Charlie Crist, the Republican governor for Florida and a leading centrist voice within his party....
...Traders said there was little fundamental to drive buying in the sector following the sharp decline in the week, which came after the bank rescue plan from Timothy Geithner, Treasury secretary, failed to...
...Investors took some comfort from the confirmation of Timothy Geithner as US Treasury secretary....
...Bristol-Myers Squibb’s board is set to meet on Tuesday as the US drugmaker faces pressure over its attempts to delay generic competition for Plavix, its most important drug....
...Their patents expired this year for US drugmakers Bristol-Myers Squibb and Merck, respectively....
...Timothy Anderson, analyst at Prudential Financial, said in a note that Pargluva’s risk/benefit profile was “a tough sell likely even when finally approved”....
...Timothy Anderson, analyst at Prudential Securities, said: ”We just don’t see Pargluva filling an unmet need in the oral anti-diabetics space.”...
...James Myers, Petco chief executive, said the fall-off in store visits did not call into question the company’s successful strategy....
...Timothy Anderson, analyst at Prudential Equity Group, said: “Just as [Wall Street's] consensus has been too high on 2005, we think the consensus is too high on 2006 and beyond”....
...Merck has also formed an alliance with Bristol-Myers Squibb to develop muraglitazar, a diabetes treatment....
International Edition